-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Serina Therapeutics, Maintains $8 Price Target

Benzinga·10/26/2026 09:51:17
語音播報
BTIG analyst Thomas Shrader reiterates Serina Therapeutics (AMEX:SER) with a Buy and maintains $8 price target.